CORC

在结果中检索

CORC

浏览/检索结果: 共26条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Phase I dose-escalation and dose-expansion trial of CDK4/6 inhibitor FCN-437c in Chinese female patients with ER+HER2-advanced breast cancer (ABC). 期刊论文
CANCER RESEARCH, 2021, 卷号: 81
作者:  Zhang, Jian;  Wang, Xiaojia;  Wang, Xian;  Hui, Aimin;  Wu, Zhuli
收藏  |  浏览/下载：22/0  |  提交时间：2021/11/01
Acid-activatible micelleplex delivering siRNA-PD-L1 for improved cancer immunotherapy of CDK4/6 inhibition 期刊论文
CHINESE CHEMICAL LETTERS, 2021, 卷号: 32, 期号: 6, 页码: 1929-1936
作者:  Gao, Jing;  Zhang, Hanwu;  Zhou, Fengqi;  Hou, Bo;  Chen, Meiwan
收藏  |  浏览/下载：17/0  |  提交时间：2021/08/17
Ki67 and progesterone receptor status predicts sensitivity to palbociclib: a real-world study 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:  Shao, Xiying;  Zheng, Yabing;  Cao, Wenming;  Shen, Xiabo;  Li, Guangliang
收藏  |  浏览/下载：52/0  |  提交时间：2021/06/15
Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2-Breast Cancer Patient With High Tumor Mutational Burden 期刊论文
FRONTIERS IN ONCOLOGY, 2021, 卷号: 10
作者:  Wang, Rong;  Yang, Yuchen;  Ye, Wei-Wu;  Xiang, Jianxing;  Chen, Songan
收藏  |  浏览/下载：44/0  |  提交时间：2021/04/26
DCZ5248, a novel dual inhibitor of Hsp90 and autophagy, exerts antitumor activity against colon cancer 期刊论文
ACTA PHARMACOLOGICA SINICA, 2020, 页码: 10
作者:  Chen, Xiang-ling;  Liu, Peng;  Zhu, Wei-liang;  Lou, Li-guang
收藏  |  浏览/下载：49/0  |  提交时间：2020/07/01
Arsenic trioxide (ATO) induced degradation of Cyclin D1 sensitized PD-1/PD-L1 checkpoint inhibitor in oral and esophageal squamous cell carcinoma 期刊论文
JOURNAL OF CANCER, 2020, 卷号: 11
作者:  Zhu, Guanxia;  Li, Xia;  Li, Jiong;  Zhou, Wei;  Chen, Zhongjian
收藏  |  浏览/下载：17/0  |  提交时间：2020/11/30
Preclinical characterization of SHR6390, a novel CDK 4/6 inhibitor, invitro and in human tumor xenograft models 期刊论文
CANCER SCIENCE, 2019, 卷号: 110, 期号: 4, 页码: 1420-1430
作者:  Long, Fei;  He, Ye;  Fu, Haoyu;  Li, Yun;  Bao, Xubin
收藏  |  浏览/下载：20/0  |  提交时间：2020/07/01
CDK4/6 inhibitor protects against myocardial cells apoptosis by inhibiting RB phosphorylation in H9c2 cells 期刊论文
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 卷号: 509, 期号: 4
作者:  Li, Jing;  Liu, Quan;  Wang, Zhenggui;  Wang, Yonggang
收藏  |  浏览/下载：14/0  |  提交时间：2019/12/05
Ribociclib, a selective cyclin D kinase 4/6 inhibitor, inhibits proliferation and induces apoptosis of human cervical cancer in vitro and in vivo 期刊论文
BIOMEDICINE & PHARMACOTHERAPY, 2019, 卷号: 112
作者:  Xiong, Yudi;  Li, Tianqi;  Assani, Ganiou;  Ling, Huan;  Zhou, Qian
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
Ribociclib, a selective cyclin D kinase 4/6 inhibitor, inhibits proliferation and induces apoptosis of human cervical cancer in vitro and in vivo. 期刊论文
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, 卷号: Vol.112, 页码: 108602
作者:  Yudi Xiong;  Tianqi Li;  Ganiou Assani;  Huan Ling;  Qian Zhou
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/17
CDK4  CDK6  Cell  apoptosis  Cell  cycle  Cervical  cancer  Ribociclib  

©版权所有 ©2017 CSpace - Powered by CSpace